The COVID-19 pandemic has hugely impacted many different aspects of human health, and vaccination is one of the most effective weapons to manage it. However, many different factors, such as age, gender, comorbidities and lifestyles, play a role in the response to infections and vaccines. We carried out this study to evaluate the potential role played by some individual factors in the production of anti-COVID-19 antibodies in the light of personalized and future vaccinology. We conducted an observational study consisting of a retrospective phase, exploiting previous data about anti-COVID-19 antibody responses, with a prospective phase to investigate individual variables through the use of a questionnaire. The antibody response after the COVI...
Background: There is debate on the necessity of booster doses of COVID-19 vaccination, especially in...
: Vaccine-induced immunity is a key strategy in the long-term control of the COVID-19 pandemic. The ...
Objective: We aimed to determine antibody (Ab) titres 3 months after the second dose of the BNT162b2...
Abstract: Population antibody surveillance helps track immune responses to COVID-19 vaccinations at ...
Background: Public health measures to stem the coronavirus disease 2019 (COVID-19) pandemic are chal...
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly understood. A range of...
Vaccination plays a key role in tackling the ongoing SARS-CoV-2 pandemic but data regarding the indi...
To date there has been limited head-to-head evaluation of immune responses to different types of COV...
Background: Two doses of mRNA vaccination have shown >94% efficacy at preventing COVID-19 mostly in ...
With the advent of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic, severa...
In December 2019, a novel respiratory coronavirus named SARS-CoV-2 appeared in China, causing the di...
The global strategy to control coronavirus disease is based on the availability of COVID-19 vaccine...
Knowledge regarding the sustainability of immune responses after COVID-19 vaccination is important, ...
Background. Prophylactic vaccination has proven to be the most effective strategy to fight the COVID...
Background: Vaccine-induced population immunity is a key global strategy to control coronavirus dise...
Background: There is debate on the necessity of booster doses of COVID-19 vaccination, especially in...
: Vaccine-induced immunity is a key strategy in the long-term control of the COVID-19 pandemic. The ...
Objective: We aimed to determine antibody (Ab) titres 3 months after the second dose of the BNT162b2...
Abstract: Population antibody surveillance helps track immune responses to COVID-19 vaccinations at ...
Background: Public health measures to stem the coronavirus disease 2019 (COVID-19) pandemic are chal...
Antibody responses to SARS-CoV-2 vaccines vary for reasons that remain poorly understood. A range of...
Vaccination plays a key role in tackling the ongoing SARS-CoV-2 pandemic but data regarding the indi...
To date there has been limited head-to-head evaluation of immune responses to different types of COV...
Background: Two doses of mRNA vaccination have shown >94% efficacy at preventing COVID-19 mostly in ...
With the advent of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic, severa...
In December 2019, a novel respiratory coronavirus named SARS-CoV-2 appeared in China, causing the di...
The global strategy to control coronavirus disease is based on the availability of COVID-19 vaccine...
Knowledge regarding the sustainability of immune responses after COVID-19 vaccination is important, ...
Background. Prophylactic vaccination has proven to be the most effective strategy to fight the COVID...
Background: Vaccine-induced population immunity is a key global strategy to control coronavirus dise...
Background: There is debate on the necessity of booster doses of COVID-19 vaccination, especially in...
: Vaccine-induced immunity is a key strategy in the long-term control of the COVID-19 pandemic. The ...
Objective: We aimed to determine antibody (Ab) titres 3 months after the second dose of the BNT162b2...